Home » Archive by Category

Articles in News

The intern life: Meet Christina Lee

August 26, 2014 – 1:33 pm | Edit Post

High-school graduate Christina Lee has spent the last three and half months learning firsthand what it’s like to work at the lab bench in a major medical research institution. After graduating from Canyon Crest Academy in June of this year, Christina has spent this summer – before packing for college – interning in our NCI-designated

Read More

Coelacanths And Other IPO Thoughts Before The Autumn Markets Return

August 26, 2014 – 6:48 am | Edit Post
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return

Ah, the final week of summer. Would that it could go on forever. And thanks for reading this on your mobile device with your toes in the sand. Just don’t forget to take a dip or toss a Frisbee…

[[Click headline to continue reading.]]

Coelacanths And Other IPO Thoughts Before The Autumn Markets Return

August 26, 2014 – 6:48 am | Edit Post
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return

Ah, the final week of summer. Would that it could go on forever. And thanks for reading this on your mobile device with your toes in the sand. Just don’t forget to take a dip or toss a Frisbee…

[[Click headline to continue reading.]]

Symphony at Salk features surprise

August 25, 2014 – 5:37 pm | Edit Post

Salk President William R. Brody demonstrated his prowess on the piano.

Finding Keys to Glioblastoma Therapeutic Resistance

August 25, 2014 – 2:03 pm | Edit Post

Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas – the primary form of a deadly brain cancer – are resistant to drug therapy. The answer lies not in the DNA sequence of the tumor, but in its epigenetic signature. These findings have been published online as a priority report in the journal Oncotarget.

Washington Monthly Ranks UC San Diego Nation’s Best University for Fifth Consecutive Year

August 25, 2014 – 8:50 am | Edit Post
Washington Monthly Ranks UC San Diego Nation’s Best University for Fifth Consecutive Year

In Washington Monthly’s annual college rankings measuring universities’ contributions to the public good, the University of California, San Diego has been rated the No. 1 college in the nation for the fifth consecutive year. The rankings are based on three categories: social mobility (recruiting and graduating low-income students), research (producing cutting-edge scholarship and Ph.D.,) and service (encouraging students to give back to their country). “It is a great honor to be recognized once again by Washington Monthly as the top college in the nation for contributing to the public good,” said Chancellor Pradeep K. Khosla. “This is an extraordinary achievement, as the criteria for this ranking exemplify our core values and our vision to be a student-centered, research-focused, service-oriented public university that provides opportunity for all.”

Washington Monthly Ranks UC San Diego Nation’s Best University for Fifth Consecutive Year

August 25, 2014 – 8:50 am | Edit Post
Washington Monthly Ranks UC San Diego Nation’s Best University for Fifth Consecutive Year

In Washington Monthly’s annual college rankings measuring universities’ contributions to the public good, the University of California, San Diego has been rated the No. 1 college in the nation for the fifth consecutive year. The rankings are based on three categories: social mobility (recruiting and graduating low-income students), research (producing cutting-edge scholarship and Ph.D.,) and service (encouraging students to give back to their country). “It is a great honor to be recognized once again by Washington Monthly as the top college in the nation for contributing to the public good,” said Chancellor Pradeep K. Khosla. “This is an extraordinary achievement, as the criteria for this ranking exemplify our core values and our vision to be a student-centered, research-focused, service-oriented public university that provides opportunity for all.”

Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis?

August 25, 2014 – 7:03 am | Edit Post
Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis?

Swiss pharmaceutical giant Roche said Sunday it would buy Intermune (NASDAQ: ITMN) of Brisbane, CA, for $8.3 billion. It’s by far the high water mark of a growing wave in recent years of deals…

[[Click headline to continue reading.]]

Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis?

August 25, 2014 – 7:03 am | Edit Post
Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis?

Swiss pharmaceutical giant Roche said Sunday it would buy Intermune (NASDAQ: ITMN) of Brisbane, CA, for $8.3 billion. It’s by far the high water mark of a growing wave in recent years of deals…

[[Click headline to continue reading.]]

In honor of the Monday morning blues, here is a sleepy Celsius quiz

August 25, 2014 – 6:04 am | Edit Post

Get Started!